{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T05:24:44Z","timestamp":1770355484708,"version":"3.49.0"},"reference-count":40,"publisher":"Zhejiang University Press","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770535"],"award-info":[{"award-number":["81770535"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600595"],"award-info":[{"award-number":["81600595"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503297"],"award-info":[{"award-number":["81503297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603340"],"award-info":[{"award-number":["81603340"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773945"],"award-info":[{"award-number":["81773945"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803775"],"award-info":[{"award-number":["81803775"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Zhejiang Provincial Natural Science Foundation of China","award":["LQ18H280005"],"award-info":[{"award-number":["LQ18H280005"]}]},{"name":"the Zhejiang Provincial Natural Science Foundation of China","award":["LY21H030002"],"award-info":[{"award-number":["LY21H030002"]}]},{"name":"the Medical Health Science and Technology Project of Zhejiang Provincial Health Commission","award":["2019RC228"],"award-info":[{"award-number":["2019RC228"]}]},{"name":"the Medical Health Science and Technology Project of Zhejiang Provincial Health Commission","award":["2019RC229"],"award-info":[{"award-number":["2019RC229"]}]},{"name":"the Medical Health Science and Technology Project of Zhejiang Provincial Health Commission","award":["2019RC113"],"award-info":[{"award-number":["2019RC113"]}]},{"name":"the Open Foundation from Chinese and Western Integrative Medicine in the Most Important Subjects of Zhejiang , China","award":["ZXYJH2018002"],"award-info":[{"award-number":["ZXYJH2018002"]}]}],"content-domain":{"domain":["springerlink.com","jzus.zju.edu.cn"],"crossmark-restriction":true},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1631\/jzus.b2000842","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T09:03:03Z","timestamp":1624611783000},"page":"492-503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Blocking the JAK2\/STAT3 and ERK pathways suppresses the proliferation of gastrointestinal cancers by inducing apoptosis","\u963b\u65adJAK2\/STAT3\u548cERK\u901a\u8def\u8bf1\u53d1\u51cb\u4ea1\u6291\u5236\u80c3\u80a0\u9053\u764c\u7684\u589e\u6b96"],"prefix":"10.1631","volume":"22","author":[{"given":"Xi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8013-9277","authenticated-orcid":false,"given":"Ke","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6247-571X","authenticated-orcid":false,"given":"Bin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"635","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"issue":"12","key":"524_CR1","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1158\/1541-7786.MCR-14-0159","volume":"12","author":"JL Anderson","year":"2014","unstructured":"Anderson JL, Titz B, Akiyama R, et al., 2014. Phosphoproteomic profiling reveals IL6-mediated paracrine signaling within the Ewing sarcoma family of tumors. Mol Cancer Res, 12(12):1740\u20131754. https:\/\/doi.org\/10.1158\/1541-7786.MCR-14-0159","journal-title":"Mol Cancer Res"},{"issue":"5","key":"524_CR2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/leu.2015.263","volume":"30","author":"E Andersson","year":"2016","unstructured":"Andersson E, Kuusanm\u00e4ki H, Bortoluzzi S, et al., 2016. Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia. Leukemia, 30(5):1204\u20131208. https:\/\/doi.org\/10.1038\/leu.2015.263","journal-title":"Leukemia"},{"issue":"6","key":"524_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/biology9060126","volume":"9","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh M, Zarrabi A, Orouei S, et al., 2020. STAT3 pathway in gastric cancer: signaling, therapeutic targeting and future prospects. Biology (Basel), 9(6): 126. https:\/\/doi.org\/10.3390\/biology9060126","journal-title":"Biology (Basel)"},{"key":"524_CR4","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s40265-019-01205-x","volume":"79","author":"HA Blair","year":"2019","unstructured":"Blair HA, 2019. Fedratinib: first approval. Drugs, 79: 1719\u20131725 https:\/\/doi.org\/10.1007\/s40265-019-01205-x","journal-title":"Drugs"},{"issue":"2","key":"524_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1182\/blood-2017-04-742288","volume":"130","author":"P Bose","year":"2017","unstructured":"Bose P, Verstovsek S, 2017. JAK2 inhibitors for myeloproliferative neoplasms: what is next? Blood, 130(2): 115\u2013125. https:\/\/doi.org\/10.1182\/blood-2017-04-742288","journal-title":"Blood"},{"issue":"3","key":"524_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.trecan.2019.02.003","volume":"5","author":"N Chatterjee","year":"2019","unstructured":"Chatterjee N, Bivona TG, 2019. Polytherapy and targeted cancer drug resistance. Trends Cancer, 5(3): 170\u2013182. https:\/\/doi.org\/10.1016\/j.trecan.2019.02.003","journal-title":"Trends Cancer"},{"key":"524_CR7","doi-asserted-by":"publisher","first-page":"764981","DOI":"10.1155\/2014\/764981","volume":"2014","author":"WB Chen","year":"2014","unstructured":"Chen WB, Wu JH, Shi H, et al., 2014. Hepatic stellate cell coculture enables sorafenib resistance in Huh7 cells through HGF\/c-Met\/Akt and Jak2\/Stat3 pathways. BioMed Res Int, 2014:764981. https:\/\/doi.org\/10.1155\/2014\/764981","journal-title":"BioMed Res Int"},{"issue":"4","key":"524_CR8","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1080\/01635581.2016.1158292","volume":"68","author":"YC Chen","year":"2016","unstructured":"Chen YC, Chien LH, Huang BM, et al., 2016. Aqueous extracts of Toona sinensis leaves inhibit renal carcinoma cell growth and migration through JAK2\/stat3, Akt, MEK\/ERK, and mTOR\/HIF-2\u03b1 pathways. Nutr Cancer, 68(4):654\u2013666. https:\/\/doi.org\/10.1080\/01635581.2016.1158292","journal-title":"Nutr Cancer"},{"key":"524_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/164_2017_20","volume":"249","author":"B Colmegna","year":"2018","unstructured":"Colmegna B, Morosi L, D\u2019Incalci M, 2018. Molecular and pharmacological mechanisms of drug resistance: an evolving paradigm. Handb Exp Pharmacol, 249:1\u201312. https:\/\/doi.org\/10.1007\/164_2017_20","journal-title":"Handb Exp Pharmacol"},{"issue":"4","key":"524_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/MPA.0b013e3181c15963","volume":"39","author":"EL Deer","year":"2010","unstructured":"Deer EL, Gonz\u00e1lez-Hern\u00e1ndez J, Coursen JD, et al., 2010. Phenotype and genotype of pancreatic cancer cell lines. Pancreas, 39(4):425\u2013435. https:\/\/doi.org\/10.1097\/MPA.0b013e3181c15963","journal-title":"Pancreas"},{"issue":"1","key":"524_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/cells9010198","volume":"9","author":"U Degirmenci","year":"2020","unstructured":"Degirmenci U, Wang M, Hu JC, 2020. Targeting aberrant RAS\/RAF\/MEK\/ERK signaling for cancer therapy. Cells, 9(1):198. https:\/\/doi.org\/10.3390\/cells9010198","journal-title":"Cells"},{"issue":"18","key":"524_CR12","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1073\/pnas.1721764115","volume":"115","author":"M Ezerskyte","year":"2018","unstructured":"Ezerskyte M, Paredes JA, Malvezzi S, et al., 2018. O6-methylguanine-induced transcriptional mutagenesis reduces p53 tumor-suppressor function. Proc Natl Acad Sci USA, 115(18):4731\u20134736. https:\/\/doi.org\/10.1073\/pnas.1721764115","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"524_CR13","first-page":"311","volume":"77","author":"DE Gerber","year":"2008","unstructured":"Gerber DE, 2008. Targeted therapies: a new generation of cancer treatments. Am Fam Physician, 77(3):311\u2013319.","journal-title":"Am Fam Physician"},{"issue":"6","key":"524_CR14","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s40257-017-0292-y","volume":"18","author":"AM Grimaldi","year":"2017","unstructured":"Grimaldi AM, Simeone E, Festino L, et al., 2017. MEK inhibitors in the treatment of metastatic melanoma and solid tumors. Am J Clin Dermatol, 18(6):745\u2013754. https:\/\/doi.org\/10.1007\/s40257-017-0292-y","journal-title":"Am J Clin Dermatol"},{"key":"524_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2017.05.033","volume":"451","author":"B Groner","year":"2017","unstructured":"Groner B, von Manstein V, 2017. Jak Stat signaling and cancer: opportunities, benefits and side effects of targeted inhibition. Mol Cell Endocrinol, 451:1\u201314. https:\/\/doi.org\/10.1016\/j.mce.2017.05.033","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"524_CR16","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3892\/etm.2020.8454","volume":"19","author":"YJ Guo","year":"2020","unstructured":"Guo YJ, Pan WW, Liu SB, et al., 2020. ERK\/MAPK signalling pathway and tumorigenesis (Review). Exp Ther Med, 19(3):1997\u20132007. https:\/\/doi.org\/10.3892\/etm.2020.8454","journal-title":"Exp Ther Med"},{"issue":"7","key":"524_CR17","doi-asserted-by":"publisher","first-page":"a026781","DOI":"10.1101\/cshperspect.a026781","volume":"7","author":"E Hirata","year":"2017","unstructured":"Hirata E, Sahai E, 2017. Tumor microenvironment and differential responses to therapy. Cold Spring Harb Perspect Med, 7(7):a026781. https:\/\/doi.org\/10.1101\/cshperspect.a026781","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10","key":"524_CR18","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, van Schaeybroeck S, Longley DB, et al., 2013. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer, 13(10):714\u2013726. https:\/\/doi.org\/10.1038\/nrc3599","journal-title":"Nat Rev Cancer"},{"key":"524_CR19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/978-981-15-0602-4_26","volume":"1206","author":"F Hua","year":"2019","unstructured":"Hua F, Li K, Shang S, et al., 2019. Immune signaling and autophagy regulation. Adv Exp Med Biol, 1206:551\u2013593. https:\/\/doi.org\/10.1007\/978-981-15-0602-4_26","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"524_CR20","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1631\/jzus.B2000190","volume":"21","author":"QQ Liu","year":"2020","unstructured":"Liu QQ, Zeng XL, Guan YL, et al., 2020. Verticillin A inhibits colon cancer cell migration and invasion by targeting c-Met. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 21(10):779\u2013795. https:\/\/doi.org\/10.1631\/jzus.B2000190","journal-title":"J Zhejiang Univ-Sci B (Biomed & Biotechnol)"},{"issue":"1","key":"524_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10555-017-9659-z","volume":"36","author":"S Meierjohann","year":"2017","unstructured":"Meierjohann S, 2017. Crosstalk signaling in targeted melanoma therapy. Cancer Metastasis Rev, 36(1):23\u201333. https:\/\/doi.org\/10.1007\/s10555-017-9659-z","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"524_CR22","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.hoc.2017.04.003","volume":"31","author":"SC Meyer","year":"2017","unstructured":"Meyer SC, 2017. Mechanisms of resistance to JAK2 inhibitors in myeloproliferative neoplasms. Hematol Oncol Clin North Am, 31(4):627\u2013642. https:\/\/doi.org\/10.1016\/j.hoc.2017.04.003","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"524_CR23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3892\/ijo.2015.3050","volume":"47","author":"T Mizukami","year":"2015","unstructured":"Mizukami T, Togashi Y, Sogabe S, et al., 2015. EGFR and HER2 signals play a salvage role in MEK1-mutated gastric cancer after MEK inhibition. Int J Oncol, 47(2):499\u2013505. https:\/\/doi.org\/10.3892\/ijo.2015.3050","journal-title":"Int J Oncol"},{"issue":"23","key":"524_CR24","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","volume":"8","author":"RB Mokhtari","year":"2017","unstructured":"Mokhtari RB, Homayouni TS, Baluch N, et al., 2017. Combination therapy in combating cancer. Oncotarget, 8(23): 38022\u201338043. https:\/\/doi.org\/10.18632\/oncotarget.16723","journal-title":"Oncotarget"},{"issue":"7","key":"524_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/17474124.2017.1312342","volume":"11","author":"YZ Nie","year":"2017","unstructured":"Nie YZ, Wu KC, Yu J, et al., 2017. A global burden of gastric cancer: the major impact of China. Expert Rev Gastroenterol Hepatol, 11(7):651\u2013661. https:\/\/doi.org\/10.1080\/17474124.2017.1312342","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"5","key":"524_CR26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1001\/jamaoncol.2015.1590","volume":"1","author":"A Pardanani","year":"2015","unstructured":"Pardanani A, Harrison C, Cortes JE, et al., 2015. Safety and efficacy of fedratinib in patients with primary or secondary myelofibrosis: a randomized clinical trial. JAMA Oncol, 1(5):643\u2013651. https:\/\/doi.org\/10.1001\/jamaoncol.2015.1590","journal-title":"JAMA Oncol"},{"key":"524_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cyto.2016.06.017","volume":"87","author":"J Pencik","year":"2016","unstructured":"Pencik J, Pham HTT, Schmoellerl J, et al., 2016. JAK-STAT signaling in cancer: from cytokines to non-coding genome. Cytokine, 87:26\u201336. https:\/\/doi.org\/10.1016\/j.cyto.2016.06.017","journal-title":"Cytokine"},{"issue":"1","key":"524_CR28","first-page":"19","volume":"8","author":"MA Pourhoseingholi","year":"2015","unstructured":"Pourhoseingholi MA, Vahedi M, Baghestani AR, 2015. Burden of gastrointestinal cancer in Asia; an overview. Gastroenterol Hepatol Bed Bench, 8(1):19\u201327.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"524_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fonc.2017.00003","volume":"7","author":"N Ramamonjisoa","year":"2017","unstructured":"Ramamonjisoa N, Ackerstaff E, 2017. Characterization of the tumor microenvironment and tumor-stroma interaction by non-invasive preclinical imaging. Front Oncol, 7:3. https:\/\/doi.org\/10.3389\/fonc.2017.00003","journal-title":"Front Oncol"},{"issue":"12","key":"524_CR30","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/nrd4281","volume":"13","author":"AA Samatar","year":"2014","unstructured":"Samatar AA, Poulikakos PI, 2014. Targeting RAS-ERK signalling in cancer: promises and challenges. Nat Rev Drug Discov, 13(12):928\u2013942. https:\/\/doi.org\/10.1038\/nrd4281","journal-title":"Nat Rev Drug Discov"},{"key":"524_CR31","doi-asserted-by":"publisher","first-page":"102016","DOI":"10.1016\/j.ctrv.2020.102016","volume":"86","author":"D Schizas","year":"2020","unstructured":"Schizas D, Charalampakis N, Kole C, et al., 2020. Immunotherapy for pancreatic cancer: a 2020 update. Cancer Treat Rev, 86:102016. https:\/\/doi.org\/10.1016\/j.ctrv.2020.102016","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"524_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00001813-200202000-00001","volume":"13","author":"P Thambi","year":"2002","unstructured":"Thambi P, Sausville EA, 2002. STI571 (imatinib mesylate): the tale of a targeted therapy. Anticancer Drugs, 13(2):111\u2013114. https:\/\/doi.org\/10.1097\/00001813-200202000-00001","journal-title":"Anticancer Drugs"},{"key":"524_CR33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13045-017-0527-7","volume":"10","author":"S Verstovsek","year":"2017","unstructured":"Verstovsek S, Gotlib J, Mesa RA, et al., 2017. Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses. J Hematol Oncol, 10:156. https:\/\/doi.org\/10.1186\/s13045-017-0527-7","journal-title":"J Hematol Oncol"},{"issue":"6","key":"524_CR34","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.devcel.2011.11.006","volume":"21","author":"G Vert","year":"2011","unstructured":"Vert G, Chory J, 2011. Crosstalk in cellular signaling: background noise or the real thing?. Dev Cell, 21(6):985\u2013991. https:\/\/doi.org\/10.1016\/j.devcel.2011.11.006","journal-title":"Dev Cell"},{"issue":"6","key":"524_CR35","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1159\/000495956","volume":"51","author":"LH Wang","year":"2018","unstructured":"Wang LH, Wu CF, Rajasekaran N, et al., 2018. Loss of tumor suppressor gene function in human cancer: an overview. Cell Physiol Biochem, 51(6):2647\u20132693. https:\/\/doi.org\/10.1159\/000495956","journal-title":"Cell Physiol Biochem"},{"key":"524_CR36","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ijbiomac.2018.05.120","volume":"116","author":"QY Wu","year":"2018","unstructured":"Wu QY, Ma MM, Fu L, et al., 2018. Roles of germline JAK2 activation mutation JAK2 V625F in the pathology of myeloproliferative neoplasms. Int J Biol Macromol, 116: 1064\u20131073. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.05.120","journal-title":"Int J Biol Macromol"},{"key":"524_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ijbiomac.2019.06.068","volume":"136","author":"QY Wu","year":"2019","unstructured":"Wu QY, Ma MM, Zhang S, et al., 2019. Disruption of R867 and Y613 interaction plays key roles in JAK2 R867Q mutation caused acute leukemia. Int J Biol Macromol, 136:209\u2013219. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.06.068","journal-title":"Int J Biol Macromol"},{"key":"524_CR38","doi-asserted-by":"publisher","first-page":"106210","DOI":"10.1016\/j.intimp.2020.106210","volume":"80","author":"P Xin","year":"2020","unstructured":"Xin P, Xu XY, Deng CJ, et al., 2020. The role of JAK\/STAT signaling pathway and its inhibitors in diseases. Int Immunopharmacol, 80:106210. https:\/\/doi.org\/10.1016\/j.intimp.2020.106210","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"524_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/jcm5040041","volume":"5","author":"JY Zhang","year":"2016","unstructured":"Zhang JY, Tian XJ, Xing JH, 2016. Signal transduction pathways of EMT induced by TGF-\u03b2, SHH, and WNT and their crosstalks. J Clin Med, 5(4):41. https:\/\/doi.org\/10.3390\/jcm5040041","journal-title":"J Clin Med"},{"issue":"10","key":"524_CR40","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1124\/dmd.114.058883","volume":"42","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Zhang Y, Diamond S, et al., 2016. The Janus kinase 2 inhibitor fedratinib inhibits thiamine uptake: a putative mechanism for the onset of Wernicke\u2019s encephalopathy. Drug Metabo Dispos, 42(10):1656\u20131662. https:\/\/doi.org\/10.1124\/dmd.114.058883","journal-title":"Drug Metabo Dispos"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2000842.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1631\/jzus.B2000842\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2000842.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T06:36:12Z","timestamp":1627367772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1631\/jzus.B2000842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["524"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b2000842","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"https:\/\/orcid.org\/0000-0002-8013-9277","URL":"http","order":0,"name":"name","label":"Ke HAO","group":{"name":"orcid","label":"ORCID"}},{"value":"https:\/\/orcid.org\/0000-0002-6247-571X","URL":"http","order":1,"name":"name","label":"Bin LU","group":{"name":"orcid","label":"ORCID"}},{"value":"doi:10.1631\/jzus.B2000190","URL":"http:\/\/www.jzus.zju.edu.cn\/article.php?doi=10.1631\/jzus.B2000190","order":0,"name":"name","label":"Verticillin A inhibits colon cancer cell...","group":{"name":"name","label":"Similar articles"}},{"value":"2020-12-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-12","order":2,"name":"crosschecked","label":"Crosschecked","group":{"name":"publication_history","label":"Publication History"}},{"value":"Article","order":0,"name":"content_type","group":{"name":"content_type","label":"Content Type"}},{"value":"\u00a9 Zhejiang University Press 2021","order":0,"name":"copyright","group":{"name":"copyright","label":"Copyright"}}]}}